1-5 of 5
Kurt W. Evans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

Timothy P. DiPeri, Kurt W. Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q. Rizvi, Xiaofeng Zheng, Bailiang Wang, Bryce P. Kirby, Kathleen Kong, Michael Kahle, Timothy A. Yap, Ecaterina E. Dumbrava, Jaffer A. Ajani, Siqing Fu, Khandan Keyomarsi, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (21): 4385–4398.
https://doi.org/10.1158/1078-0432.CCR-23-0103
Published: 01 November 2023
View article titled, Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers
Open the PDF for Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers in another window
Includes: Supplementary data
Journal Articles

Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer

Ming Zhao, Stephen Scott, Kurt W. Evans, Erkan Yuca, Turcin Saridogan, Xiaofeng Zheng, Heping Wang, Anil Korkut, Christian X. Cruz Pico, Mehmet Demirhan, Bryce Kirby, Scott Kopetz, Irmina Diala, Alshad S. Lalani, Sarina Piha-Paul, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6): 1681–1694.
https://doi.org/10.1158/1078-0432.CCR-20-3017
Published: 15 March 2021
View article titled, Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer
Open the PDF for Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer in another window
Journal Articles

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

Xian Chen, Kwang-Huei Low, Angela Alexander, Yufeng Jiang, Cansu Karakas, Kenneth R. Hess, Jason P.W. Carey, Tuyen N. Bui, Smruthi Vijayaraghavan, Kurt W. Evans, Min Yi, D. Christian Ellis, Kwok-Leung Cheung, Ian O. Ellis, Siqing Fu, Funda Meric-Bernstam, Kelly K. Hunt, Khandan Keyomarsi
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6594–6610.
https://doi.org/10.1158/1078-0432.CCR-18-1446
Published: 13 December 2018
View article titled, Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Open the PDF for Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition in another window
Includes: Supplementary data
Journal Articles

A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors

Kurt W. Evans, Erkan Yuca, Argun Akcakanat, Stephen M. Scott, Natalia Paez Arango, Xiaofeng Zheng, Ken Chen, Coya Tapia, Emily Tarco, Agda K. Eterovic, Dalliah M. Black, Jennifer K. Litton, Timothy A. Yap, Debu Tripathy, Gordon B. Mills, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (21): 6468–6477.
https://doi.org/10.1158/1078-0432.CCR-17-0615
Published: 31 October 2017
View article titled, A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors
Open the PDF for A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract A39: Patient-derived xenografts to test emerging therapies for triple negative breast cancer

Kurt W. Evans, Erkan Yuca, Stephen M. Scott, Natalia Arango Paez, Xiaofeng Zheng, Ken Chen, Laura Gonzales, Coya Tapia, Emily Tarco, Dalliah M. Black, Gordon B. Mills, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): A39.
https://doi.org/10.1158/1557-3265.PDX16-A39
Published: 15 August 2016
View article titled, Abstract A39: Patient-derived xenografts to test emerging therapies for triple negative breast cancer